Key Takeaways
- Standard Dosage Range: GHRP-2 is typically administered in doses ranging from 100 to 300 mcg per injection.
- Administration Method: Most commonly delivered via subcutaneous injection, though other forms exist.
- Typical Cycle Length: Often used in cycles of 4 to 12 weeks, with possible breaks in between.
- Regulatory Status: GHRP-2 is not FDA-approved and is available for research purposes only.
- Medical Supervision: Essential to consult with a healthcare provider to tailor dosing to individual needs and ensure safety.
How GHRP-2 Works in the Body
GHRP-2, or Growth Hormone-Releasing Peptide 2, is a synthetic hexapeptide that functions as a potent growth hormone secretagogue. It primarily works by binding to the ghrelin receptor (GHS-R1a), thereby activating Gq/PLC and calcium-mediated signaling pathways. This action stimulates the pituitary gland to release growth hormone (GH), which can lead to various physiological effects such as increased muscle mass and reduced body fat.
The half-life of GHRP-2 is relatively short, around 15 to 60 minutes, which necessitates multiple daily administrations to maintain stable plasma levels. Its bioavailability varies depending on the administration route, with subcutaneous injections offering a more direct and efficient delivery compared to oral forms.
A drug profile published in Drugs in R&D (PMID 15230633) describes GHRP-2 (pralmorelin) as markedly increasing plasma GH in healthy subjects irrespective of gender, obesity or age, which is the basis for its use as a diagnostic agent for GH deficiency. Preclinical work in Arzneimittel-Forschung (Doi N et al., PMID 15646370) characterised its GH-releasing activity in rats, finding the response stable in comparison with exogenously injected GH-releasing hormone (GHRH) in vivo — though notably weaker than GHRH in cultured pituitary cells. Human dose-response data remain limited.
Standard GHRP-2 Dosage Ranges (By Form)
| Form | Dosage Range | Frequency | Bioavailability | Commonality |
|---|---|---|---|---|
| Subcutaneous injection | 100–300 mcg per injection | 1–3 times daily | High — direct absorption into the bloodstream | Most prevalent form, for ease of use and effective absorption |
| Intramuscular injection | 100–300 mcg per injection | 1–3 times daily | Comparable to subcutaneous | Less commonly used, due to discomfort |
| Oral | Higher doses required | 2–3 times daily | Significantly lower than injectable forms | Least efficient GH release |
Comparison
Subcutaneous injections are preferred for their high bioavailability and ease of administration. Oral forms, while available, require higher doses and are less effective due to first-pass metabolism.
GHRP-2 Dosage by Use Case
| Goal | Typical Dosage | Method | Cycle Length |
|---|---|---|---|
| Muscle growth and fat loss | 100–200 mcg per injection | Subcutaneous | 8–12 weeks |
| Anti-aging and general well-being | 100 mcg per injection | Subcutaneous | Continuous with periodic breaks |
| Endocrine research and hormone regulation | 100–300 mcg per injection | Subcutaneous | Variable, depending on research protocol |
Muscle growth and fat loss. A review of growth hormone secretagogues as a class reports improvements in lean mass in wasting states and in obese individuals (PMID 28400207). Many clinics prescribe GHRP-2 in conjunction with lifestyle modifications such as diet and exercise for optimal results.
Anti-aging and general well-being. Anecdotal reports and preliminary studies suggest benefits in energy levels and skin elasticity. Clinical protocols typically recommend lower doses to minimize potential side effects.
Endocrine research and hormone regulation. Research protocols often explore various dosing strategies to elucidate endocrine responses.
How Long Should You Take GHRP-2?
GHRP-2 is commonly used in cycles of 4 to 12 weeks, depending on the therapeutic goal.
| Timeframe | What users typically report |
|---|---|
| Weeks 1–2 | Increased energy and improved sleep |
| Weeks 3–4 | More noticeable changes in body composition — increased muscle mass, reduced fat |
| After 6 weeks | Effects stabilize; a break may be recommended to prevent receptor desensitization |
Tapering is generally not required, but a gradual reduction in frequency may be beneficial for some users. When discontinuing GHRP-2, hormone levels typically return to baseline without significant withdrawal effects.
Administration Protocol: How to Take GHRP-2
| Parameter | Specification |
|---|---|
| Needle gauge | 29–31 gauge |
| Injection sites | Rotate between abdomen, thigh, and upper arm to prevent tissue damage |
| Rotation schedule | Change sites with each injection to avoid irritation |
| Oral timing | Best taken on an empty stomach to enhance absorption |
| Food interaction | Avoid high-fat meals around dosing times |
| Storage temperature | 2–8°C (refrigerated) |
| Light sensitivity | Protect from light |
| Reconstituted stability | Use within 48 hours of reconstitution |
Reconstitution Instructions
Mix with bacteriostatic water according to the manufacturer's instructions. See our reconstitution guide for detailed steps.
Step-by-Step Administration Process
- Preparation: Wash hands and prepare the injection site with an alcohol swab.
- Reconstitution: Use a sterile syringe to mix the peptide with bacteriostatic water.
- Drawing the Dose: Withdraw the desired amount into the syringe.
- Injection: Pinch the skin and insert the needle at a 45-degree angle for subcutaneous injections.
- Post-Injection: Apply slight pressure with a cotton pad and dispose of the needle safely.
Stacking GHRP-2 for Better Results
| Stack | Dosing synergy | Effect | Protocol use |
|---|---|---|---|
| GHRP-2 + CJC-1295 | GHRP-2 at 100–200 mcg with CJC-1295 at 100 mcg | Enhances GH release synergistically | Muscle-building and anti-aging protocols |
| GHRP-2 + Ipamorelin | GHRP-2 at 100 mcg with Ipamorelin at 100 mcg | Dual approach to GH release with reduced side effects | Wellness and recovery protocols |
| Wolverine Protocol | Specific doses vary; consult clinical protocols | Reputed regenerative effects | GHRP-2 with BPC-157 and TB-500 for enhanced recovery |
Factors That Affect Your GHRP-2 Dosage
Several factors influence the appropriate GHRP-2 dosage, including:
- Body Weight: Larger individuals may require higher doses for the same effect.
- Age: Older adults may have different receptor sensitivities.
- Treatment Goals: Specific objectives such as muscle gain or fat loss dictate dosing strategies.
- Kidney/Liver Function: Impaired function may necessitate dose adjustments.
- Other Medications: Concurrent medications can affect peptide metabolism and efficacy.
- Individual Response: Genetic factors and personal health history play a role in dosage determination.
